Bioengineering researchers at the University of Notre Dame are joining a consortium focusing on regenerative medicine. The Advanced Regenerative Manufacturing Institute is bringing together academic, industry, government and nonprofit experts to develop innovative technologies.
The ARMI is focusing on "accelerating regenerative tissue research and creating state-of-the-art manufacturing innovations in biomaterial and cell processing for critical Department of Defense and civilian needs," according to Notre Dame. The university says its scientists will focus on advanced tissue biofabrication and making current technologies available to patients in need.
"We’re looking forward to collaborating with this group of industrial and academic partners," said Glen Niebur, director of the bioengineering graduate program at Notre Dame. "Through our affiliation with ARMI, we have a great opportunity to contribute to making regenerative medicine products a reality."
The consortium includes 47 industrial partners, 26 academic and academically-affiliated partners and 14 government and nonprofit partners. The U.S. Department of Defense is awarding $80 million, which is being combined with more than $200 million in cost share to support the research.